Antigen Information
General Information of This Antigen
| Antigen ID | TAR0AABNG |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | Sodium-dependent phosphate transport protein 2B (SLC34A2) |
|||||
| Gene Name | SLC34A2 |
|||||
| Gene ID | ||||||
| Synonym | Na(+)-dependent phosphate cotransporter 2B;NaPi3b;Sodium/phosphate cotransporter 2B;Solute carrier family 34 member 2 |
|||||
| Sequence |
MAPWPELGDAQPNPDKYLEGAAGQQPTAPDKSKETNKTDNTEAPVTKIELLPSYSTATLI
DEPTEVDDPWNLPTLQDSGIKWSERDTKGKILCFFQGIGRLILLLGFLYFFVCSLDILSS AFQLVGGKMAGQFFSNSSIMSNPLLGLVIGVLVTVLVQSSSTSTSIVVSMVSSSLLTVRA AIPIIMGANIGTSITNTIVALMQVGDRSEFRRAFAGATVHDFFNWLSVLVLLPVEVATHY LEIITQLIVESFHFKNGEDAPDLLKVITKPFTKLIVQLDKKVISQIAMNDEKAKNKSLVK IWCKTFTNKTQINVTVPSTANCTSPSLCWTDGIQNWTMKNVTYKENIAKCQHIFVNFHLP DLAVGTILLILSLLVLCGCLIMIVKILGSVLKGQVATVIKKTINTDFPFPFAWLTGYLAI LVGAGMTFIVQSSSVFTSALTPLIGIGVITIERAYPLTLGSNIGTTTTAILAALASPGNA LRSSLQIALCHFFFNISGILLWYPIPFTRLPIRMAKGLGNISAKYRWFAVFYLIIFFFLI PLTVFGLSLAGWRVLVGVGVPVVFIIILVLCLRLLQSRCPRVLPKKLQNWNFLPLWMRSL KPWDAVVSKFTGCFQMRCCCCCRVCCRACCLLCDCPKCCRCSKCCEDLEEAQEGQDVPVK APETFDNITISREAQGEVPASDSKTECTAL Click to Show/Hide
|
|||||
| Family | SEZ6 family |
|||||
| Function |
Involved in actively transporting phosphate into cells via Na(+) cotransport.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
10H1.11.4B
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN109310885B ADC-4 |
CN109310885B ADC-4 payload |
Undisclosed |
CN109310885B ADC-4 linker |
[1] | |
CN109310885B ADC-5 |
CN109310885B ADC-5 payload |
Undisclosed |
CN109310885B ADC-5 linker |
[1] | |
CN109310885B ADC-6 |
CN109310885B ADC-6 payload |
Undisclosed |
CN109310885B ADC-6 linker |
[1] | |
CN109310885B ADC-9 |
CN109310885B ADC-9 payload |
Undisclosed |
CN109310885B ADC-9 linker |
[1] | |
CN109310885B ADC-10 |
CN109310885B ADC-10 payload |
Undisclosed |
CN109310885B ADC-10 linker |
[1] |
10H1.11.4B LC A149C
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN106714844B ADC-121 |
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
[2] | |
CN106714844B ADC-123 |
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
[2] | |
CN106714844B ADC-125 |
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
[2] | |
CN106714844B ADC-127 |
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
[2] | |
CN107206101B ADC-1 |
Dolastatin10 |
Undisclosed |
MC-Sq-CIt-PAB |
[3] | |
CN107206101B ADC-2-1 |
Tubulysin M |
Undisclosed |
MC-Sq-CIt-PAB |
[3] | |
Anti- Napi2b Disulfide-Tubulysin M |
Tubulysin M |
Undisclosed |
Disulfide linker |
[3] |
10H1.11B HC A118C
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN106714844B ADC-106 |
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
[2] | |
CN106714844B ADC-113 |
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
[2] |
Anti-NaPi-2b antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
XMT-1592 |
AF-HPA |
Microtubule (MT) |
Cys-13 ADC linker |
Anti-Napi2b Fc-silenced IgG1 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
TUB-040 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
P5 (PEG24)-Val-Cit-PABC |
Anti-NaPi2b mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
YL205 |
YL0010014 |
DNA topoisomerase 1 (TOP1) |
VK*G-NHCH2-O linker |
Anti-NaPi2b mAb 10H1.11.4B
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
NaPi2b PNU ADC3-1 |
NaPi2b PNU ADC3-1 payload |
Undisclosed |
NaPi2b PNU ADC3-1 linker |
[4] | |
NaPi2b PNU ADC4-1 |
NaPi2b PNU ADC4-1 payload |
Undisclosed |
NaPi2b PNU ADC4-1 linker |
[4] | |
NaPi2b-PNU-LD1 |
NaPi2b-PNU-LD1 payload |
Undisclosed |
NaPi2b-PNU-LD1 linker |
[4] | |
NaPi2b-PNU-LD2 |
NaPi2b-PNU-LD2 payload |
Undisclosed |
NaPi2b-PNU-LD2 linker |
[4] | |
NaPi2b-PNU-LD5 |
NaPi2b-PNU-LD5 payload |
Undisclosed |
NaPi2b-PNU-LD5 linker |
[4] | |
NaPi2b-PNU-LD6 |
NaPi2b-PNU-LD6 payload |
Undisclosed |
NaPi2b-PNU-LD6 linker |
[4] | |
NaPi2b-PNU-LD7 |
NaPi2b-PNU-LD7 payload |
Undisclosed |
NaPi2b-PNU-LD7 linker |
[4] |
Anti-NaPi2b-LC-K149C
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Alpha-NaPi2b-LC-K149C-10 |
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mc-peptidomimetic based linker 10 |
[5] | |
Alpha-NaPi2b-LC-K149C-11 |
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2 |
[5] |
CN105828840B_ADC-134 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN105828840B ADC-134 |
CN105828840B_ADC-134 payload |
Undisclosed |
CN105828840B_ADC-134 linker |
[6] |
CN105828840B_ADC-135 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN105828840B ADC-135 |
CN105828840B_ADC-135 payload |
Undisclosed |
CN105828840B_ADC-135 linker |
[6] |
CN105828840B_ADC-136 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN105828840B ADC-136 |
CN105828840B_ADC-136 payload |
Undisclosed |
CN105828840B_ADC-136 linker |
[6] |
Fully humanized Anti-SLC34A2 IgG1 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
ZW-220 |
ZD06519 |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly-AM |
[7] |
Lifastuzumab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Lifastuzumab vedotin |
MMAE |
Microtubule (MT) |
Mc-Val-Cit-PABC |
OT1:cHv83-1b15.G1 (L328C)k
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AGL-01332-93 (BrAc) 2.43 |
CN114929286A 93 |
Undisclosed |
AGL-01332 linker |
[8] | |
AGL-01332-93CI 2.19 |
CN114929286A 93CI |
Undisclosed |
AGL-01332 linker |
[8] |
OT1:cHv83-3a23.G1 (L328C)k
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AGL-01332-93 (BrAc) 1.98 |
CN114929286A 93 |
Undisclosed |
AGL-01332 linker |
[8] | |
AGL-01332-93CI 1.82 |
CN114929286A 93CI |
Undisclosed |
AGL-01332 linker |
[8] |
Thio Anti-Napi2B 10H1.11.4B LC V205C
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2017214024A1 ADC-102 |
WO2017214024A1_ADC-102 payload |
Undisclosed |
WO2017214024A1_ADC-102 linker |
[9] |
Thio hu Anti-NaPi2b 10H1.11.4B LC K149C
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2017059289A1 ADC-208 |
WO2017059289A1_ADC-208 payload |
Undisclosed |
WO2017059289A1_ADC-208 linker |
[10] |
Thio hu Anti-Napi3b 10H1.11.4B HC A118C
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2014159981A2 ADC-205 |
WO2014159981A2_ADC-205 payload |
Undisclosed |
WO2014159981A2_ADC-205 linker |
[11] | |
WO2014159981A2 ADC-SLC34A2-33 |
WO2014159981A2_ADC-SLC34A2-33 payload |
Undisclosed |
WO2014159981A2_ADC-SLC34A2-33 linker |
[11] | |
WO2014159981A2 ADC-SLC34A2-37 |
WO2014159981A2_ADC-SLC34A2-37 payload |
Undisclosed |
WO2014159981A2_ADC-SLC34A2-37 linker |
[11] |
Upifitamab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Upifitamab rilsodotin |
AF-HPA |
Microtubule (MT) |
Dolaflexin polymer |
XMT-1535
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2018098269A2 conjugate 53A |
WO2018098269A2_conjugate 53A payload |
Undisclosed |
WO2018098269A2_conjugate 53A linker |
[12] | |
WO2018098269A2 conjugate 55A |
WO2018098269A2_conjugate 55A payload |
Undisclosed |
WO2018098269A2_conjugate 55A linker |
[12] | |
WO2018098269A2 conjugate 57 |
WO2018098269A2_conjugate 57 payload |
Undisclosed |
WO2018098269A2_conjugate 57 linker |
[12] | |
WO2018098269A2 conjugate 59 |
WO2018098269A2_conjugate 59 payload |
Undisclosed |
WO2018098269A2_conjugate 59 linker |
[12] | |
WO2018098269A2 conjugate 61 |
WO2018098269A2_conjugate 61 payload |
Undisclosed |
WO2018098269A2_conjugate 61 linker |
[12] | |
WO2018098269A2 conjugate 66 |
WO2018098269A2_conjugate 66 payload |
Undisclosed |
WO2018098269A2_conjugate 66 linker |
[12] | |
WO2018098269A2 conjugate 79A |
WO2018098269A2_conjugate 79A payload |
Undisclosed |
WO2018098269A2_conjugate 79A linker |
[12] | |
WO2018098269A2 conjugate 76 |
WO2018098269A2_conjugate 76 payload |
Undisclosed |
WO2018098269A2_conjugate 76 linker |
[12] | |
WO2018098269A2 conjugate 83 |
WO2018098269A2_conjugate 83 payload |
Undisclosed |
WO2018098269A2_conjugate 83 linker |
[12] | |
WO2018098269A2 conjugate 78 |
WO2018098269A2_conjugate 78 payload |
Undisclosed |
WO2018098269A2_conjugate 78 linker |
[12] | |
WO2018098269A2 conjugate 85 |
WO2018098269A2_conjugate 85 payload |
Undisclosed |
WO2018098269A2_conjugate 85 linker |
[12] | |
WO2018098269A2 conjugate 53B |
WO2018098269A2_conjugate 53B payload |
Undisclosed |
WO2018098269A2_conjugate 53B linker |
[12] | |
WO2018098269A2 conjugate 53C |
WO2018098269A2_conjugate 53C payload |
Undisclosed |
WO2018098269A2_conjugate 53C linker |
[12] | |
WO2018098269A2 conjugate 53D |
WO2018098269A2_conjugate 53D payload |
Undisclosed |
WO2018098269A2_conjugate 53D linker |
[12] | |
WO2018098269A2 conjugate 53E |
WO2018098269A2_conjugate 53E payload |
Undisclosed |
WO2018098269A2_conjugate 53E linker |
[12] | |
WO2018098269A2 conjugate 55B |
WO2018098269A2_conjugate 55B payload |
Undisclosed |
WO2018098269A2_conjugate 55B linker |
[12] | |
WO2018098269A2 conjugate 79B |
WO2018098269A2_conjugate 79B payload |
Undisclosed |
WO2018098269A2_conjugate 79B linker |
[12] | |
CN109310885B ADC-1 |
CN109310885B ADC-1 payload |
Undisclosed |
CN109310885B ADC-1 linker |
[1] | |
CN109310885B ADC-2 |
CN109310885B ADC-2 payload |
Undisclosed |
CN109310885B ADC-2 linker |
[1] | |
CN109310885B ADC-3 |
CN109310885B ADC-3 payload |
Undisclosed |
CN109310885B ADC-3 linker |
[1] | |
AU2017363246B2 Conjugate53A |
AU2017363246B2+Conjugate53+Payload |
Undisclosed |
AU2017363246B2+Conjugate53+Linker |
[13] | |
AU2017363246B2 Conjugate53B |
AU2017363246B2+Conjugate53+Payload |
Undisclosed |
AU2017363246B2+Conjugate53+Linker |
[13] | |
AU2017363246B2 Conjugate53C |
AU2017363246B2+Conjugate53+Payload |
Undisclosed |
AU2017363246B2+Conjugate53+Linker |
[13] | |
AU2017363246B2 Conjugate53D |
AU2017363246B2+Conjugate53+Payload |
Undisclosed |
AU2017363246B2+Conjugate53+Linker |
[13] | |
AU2017363246B2 Conjugate53E |
AU2017363246B2+Conjugate53+Payload |
Undisclosed |
AU2017363246B2+Conjugate53+Linker |
[13] | |
AU2017363246B2 Conjugate55A |
AU2017363246B2+Conjugate55+Payload |
Undisclosed |
AU2017363246B2+Conjugate55+Linker |
[13] | |
AU2017363246B2 Conjugate55B |
AU2017363246B2+Conjugate55+Payload |
Undisclosed |
AU2017363246B2+Conjugate55+Linker |
[13] | |
AU2017363246B2 Conjugate55C |
AU2017363246B2+Conjugate55+Payload |
Undisclosed |
AU2017363246B2+Conjugate55+Linker |
[13] | |
AU2017363246B2 Conjugate57 |
AU2017363246B2+Conjugate57+Payload |
Undisclosed |
AU2017363246B2+Conjugate57+Linker |
[13] | |
AU2017363246B2 Conjugate59 |
AU2017363246B2+Conjugate59+Payload |
Undisclosed |
AU2017363246B2+Conjugate59+Linker |
[13] | |
AU2017363246B2 Conjugate61 |
AU2017363246B2+Conjugate61+Payload |
Undisclosed |
AU2017363246B2+Conjugate61+Linker |
[13] | |
AU2017363246B2 Conjugate66 |
AU2017363246B2+Conjugate66+Payload |
Undisclosed |
AU2017363246B2+Conjugate66+Linker |
[13] | |
AU2017363246B2 Conjugate76 |
AU2017363246B2+Conjugate76+Payload |
Undisclosed |
AU2017363246B2+Conjugate76+Linker |
[13] | |
AU2017363246B2 Conjugate78 |
AU2017363246B2+Conjugate78+Payload |
Undisclosed |
AU2017363246B2+Conjugate78+Linker |
[13] | |
AU2017363246B2 Conjugate79A |
AU2017363246B2+Conjugate79+Payload |
Undisclosed |
AU2017363246B2+Conjugate79+Linker |
[13] | |
AU2017363246B2 Conjugate79B |
AU2017363246B2+Conjugate79+Payload |
Undisclosed |
AU2017363246B2+Conjugate79+Linker |
[13] | |
AU2017363246B2 Conjugate83 |
AU2017363246B2+Conjugate83+Payload |
Undisclosed |
AU2017363246B2+Conjugate83+Linker |
[13] | |
AU2017363246B2 Conjugate85 |
AU2017363246B2+Conjugate85+Payload |
Undisclosed |
AU2017363246B2+Conjugate85+Linker |
[13] | |
WO2019126691A1 Conjugate No.20A |
Conjugate No.10 Payload |
Undisclosed |
Conjugate No.5 Linker |
[14] | |
WO2019126691A1 Conjugate No.73A |
Conjugate No.67 Payload |
Undisclosed |
Conjugate No.73 Linker |
[14] | |
WO2019126691A1 Conjugate No.94A |
Conjugate No.94 Payload |
Undisclosed |
Conjugate No.94 Linker |
[14] | |
WO2019126691A1 Conjugate No.135 |
Conjugate No.135 Payload |
Undisclosed |
Conjugate No.105 Linker |
[14] | |
WO2019126691A1 Conjugate No.136 |
Conjugate No.136 Payload |
Undisclosed |
Conjugate No.105 Linker |
[14] |
Undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
BSI-715 |
Undisclosed |
Undisclosed |
Undisclosed |
[15] | |
Anti-NaPi3b antibody-drug conjugate (Genentech/Roche) |
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
[16] |
undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
NaPi2b-STINGa |
STINGa |
Undisclosed |
Undisclosed |
[17] | |
ADRX-0134 |
AP052 |
Microtubule (MT) |
Undisclosed |
[18] |
References
